Role of the latest endovascular technology in the treatment of intermittent claudication

References

• RoseGABlackburnHCardiovascular survey methodsMonogr Ser World Health Organ1968561188
   PubMedGoogle Scholar
• RegensteinerJGHiattWRCollJRThe impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) ProgramVasc Med200813152418372434
   PubMed Web of Science ®Google Scholar
• McDermottMMLiuKGreenlandPFunctional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptomsJAMA200429245346115280343
   PubMed Web of Science ®Google Scholar
• McDermottMMMedications for improving walking performance in peripheral artery disease: still miles to goJAMA201330948748823385276
   PubMed Web of Science ®Google Scholar
• MomsenAHJensenMBNoragerCBDrug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomized controlled studiesEur J Vasc Endovasc Surg20093846347419586783
   PubMed Web of Science ®Google Scholar
• McDermottMMAdesPGuralnikJMTreadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trialJAMA200930116517419141764
   PubMed Web of Science ®Google Scholar
• NorgrenLHiattWRDormandyJATASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II)J Vasc Surg200745S5S6717223489
   PubMed Web of Science ®Google Scholar
• RoweVLLeeWWeaverFAEtzioniDPatterns of treatment for peripheral arterial disease in the United States: 1996–2005J Vasc Surg20094991091719341885
   PubMed Web of Science ®Google Scholar
• SchillingerMMinarEPercutaneous treatment of peripheral artery disease: novel techniquesCirculation20121262433244023147770
   PubMed Web of Science ®Google Scholar
• O’Brien-IrrMSHarrisLMDosluogluHHDryjskiMLEndovascular intervention for treatment of claudication: is it cost-effective?Ann Vasc Surg20102483384020638623
   PubMed Web of Science ®Google Scholar
• AhimastosAAPappasEPButtnerPGWalkerPJKingwellBAGolledgeJA meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudicationJ Vasc Surg2011541511152121958561
   PubMed Web of Science ®Google Scholar
• IchihashiSHigashiuraWItohHSakaguchiSNishimineKKichikawaKLong-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-IIJ Vasc Surg20115399299921215582
   PubMed Web of Science ®Google Scholar
• SogaYIidaOKawasakiDContemporary outcomes after endovascular treatment for aorto-iliac artery diseaseCirc J2012762697270422864278
   PubMed Web of Science ®Google Scholar
• BalzerJOThalhammerAKhanVZangosSVoglTJLehnertTAngioplasty of the pelvic and femoral arteries in PAOD: results and review of the literatureEur J Radiol201075485620451340
   PubMed Web of Science ®Google Scholar
• SixtSKrankenbergHMöhrleCEndovascular treatment for extensive aortoiliac artery reconstruction: a single-center experience based on 1712 interventionsJ Endovasc Ther201320647323391085
   PubMed Web of Science ®Google Scholar
• OzkanUOguzkurtLTercanFTechnique, complication, and long-term outcome for endovascular treatment of iliac artery occlusionCardiovasc Intervent Radiol201033182419768500
   PubMed Web of Science ®Google Scholar
• IndesJEPfaffMJFarrokhyarFClinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysisJ Endovasc Ther20132044345523914850
   PubMed Web of Science ®Google Scholar
• AbuRahmaAFHayesJDFlahertySKPeeryWPrimary iliac stenting versus transluminal angioplasty with selective stentingJ Vasc Surg20074696597017905559
   PubMed Web of Science ®Google Scholar
• ScheinertDScheinertSSaxJPrevalence and clinical impact of stent fractures after femoropopliteal stentingJ Am Coll Cardiol20054531231515653033
   PubMed Web of Science ®Google Scholar
• SchillingerMSabetiSLoeweCBalloon angioplasty versus implantation of nitinol stents in the superficial femoral arteryN Engl J Med20063541879188816672699
   PubMed Web of Science ®Google Scholar
• BosiersMTorselloGGisslerHMNitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I studyJ Endovasc Ther20091626126919642788
   PubMed Web of Science ®Google Scholar
• LairdJRKatzenBTScheinertDNitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trialCirc Cardiovasc Interv2010326727620484101
   PubMed Web of Science ®Google Scholar
• SogaYIidaOHiranoKYokoiHNantoSNobuyoshiMMid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stentJ Vasc Surg20105260861520573476
   PubMed Web of Science ®Google Scholar
• DohiTIidaOSogaYIncidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesionsJ Vasc Surg20145910091015e124360237
   PubMed Web of Science ®Google Scholar
• AxelDIKunertWGoggelmannCPaclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug deliveryCirculation1997966366459244237
   PubMed Web of Science ®Google Scholar
• DakeMDAnselGMJaffMRSustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studiesJ Am Coll Cardiol2013612417242723583245
   PubMed Web of Science ®Google Scholar
• AnselGZilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal artery disease: 4 year resultsAbstract presented at the 2013 Vascular Interventional Advances meetingLas Vegas, NV, USAOctober 8–11, 2013
   Google Scholar
• De CockESapovalMJuliaPde LissovoyGLopesSA budget impact model for paclitaxel-eluting stent in femoropopliteal disease in FranceCardiovasc Intervent Radiol20133636237023073560
   PubMed Web of Science ®Google Scholar
• KedoraJHohmannSGarrettWMunschaurCTheuneBGableDRandomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive diseaseJ Vasc Surg200745101617126520
   PubMed Web of Science ®Google Scholar
• McQuadeKGableDPearlGTheuneBBlackSFour-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive diseaseJ Vasc Surg20105258459020598480
   PubMed Web of Science ®Google Scholar
• LammerJZellerTHauseggerKAHeparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease)J Am Coll Cardiol2013621320132723831445
   PubMedGoogle Scholar
• JonerMFinnAVFarbAPathology of drug eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol20064819320216814667
   PubMed Web of Science ®Google Scholar
• FarhatniaYTanAMotiwalaACousinsBGSeifalianAMEvolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnologyBiotechnol Adv20133152454223305892
   PubMed Web of Science ®Google Scholar
• SaxonRRChervuAJonesPAHeparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trialJ Vasc Interv Radiol20132416517323369553
   PubMed Web of Science ®Google Scholar
• RyerEJTrocciolaSMDeRubertisBAnalysis of outcomes following failed endovascular treatment of chronic limb ischemiaAnn Vasc Surg20062044044616865606
   PubMed Web of Science ®Google Scholar
• AmblerGKRadwanRHayesPDTwineCPAtherectomy for peripheral arterial diseaseCochrane Database Syst Rev20143CD00668024638972
   PubMedGoogle Scholar
• TepeGZellerTAlbrechtTLocal delivery of paclitaxel to inhibit restenosis during angioplasty of the legN Engl J Med200835868969918272892
   PubMed Web of Science ®Google Scholar
• WerkMLangnerSReinkensmeierBInhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trialCirculation20081181358136518779447
   PubMed Web of Science ®Google Scholar
• ScheinertDDudaSZellerTThe LEVANT I (lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplastyJACC Cardiovasc Interv20147101924456716
   PubMed Web of Science ®Google Scholar
• CioppaAStabileEPopusoiGCombined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical resultsCardiovasc Revasc Med20121321922322632996
   PubMedGoogle Scholar
• ZellerTDirectional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: a pilot study of anti- restenosis treatmentAbstract presented at the 2013 Vascular Interventional Advances meetingLas Vegas, NV, USAOctober 8–11, 2013
   Google Scholar
• ZellerTDEB vs PTA for infrapopliteal revascularisation: 12 months results from the IN.PACT DEEP randomized trialAbstract presented at the Leipzig Interventional CourseLeipzig, GermanyJanuary 27–31, 2013
   Google Scholar
• OnumaYSerruysPWBioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?Circulation201112377979721343594
   PubMed Web of Science ®Google Scholar
• NairLSLaurencinCTBiodegradable polymers as biomaterialsProg Polym Sci200732762798
   Web of Science ®Google Scholar
• TamaiHIgakiKKyoEInitial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humansCirculation200010239940410908211
   PubMed Web of Science ®Google Scholar
• NishioSKosugaKIgakiKLong-term (>10 years) clinical outcomes of first-in-human biodegradable poly-L-lactic acid coronary stents: Igaki-Tamai stentsCirculation20121252343235322508795
   PubMed Web of Science ®Google Scholar
• BiaminoGSchmidtAScheinertDTreatment of SFA lesions with PLLA biodegradable stents: results of the PERSEUS studyJ Endovasc Ther2005125
   Web of Science ®Google Scholar
• LammerJEvaluation of Esprit BVS in the treatment of patients with occlusive vascular disease of the superficial femoral artery (SFA) or common or external iliac arteriesAbstract presented at the 2013 Vascular Interventional Advances meetingLas Vegas, NV, USAOctober 8–11, 2013
   Google Scholar
• ChetterICSparkJIKentPJBerridgeDCScottDJKesterRCPercutaneous transluminal angioplasty for intermittent claudication: evidence on which to base the medicineEur J Vasc Endovasc Surg1998164774849894486
   PubMed Web of Science ®Google Scholar
• GreenhalghRMBelchJJBrownLCThe adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial diseaseEur J Vasc Endovasc Surg20083668068819022184
   PubMed Web of Science ®Google Scholar
• IchihashiSHigashiuraWItohHSakaguchiSKichikawaKIliac artery stent placement relieves claudication in patients with iliac and superficial femoral artery lesionsCardiovasc Intervent Radiol20133662362822692181
   PubMed Web of Science ®Google Scholar
• FakhryFvan de LuijtgaardenKMBaxLSupervised walking therapy in patients with intermittent claudicationJ Vasc Surg2012561132114223026425
   PubMed Web of Science ®Google Scholar
• SpronkSBoschJLden HoedPTCost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trialJ Vasc Surg2008481472148018771879
   PubMed Web of Science ®Google Scholar
• MurphyTPCutlipDERegensteinerJGSupervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) studyCirculation201212513013922090168
   PubMed Web of Science ®Google Scholar
• FransFABipatSReekersJALegemateDAKoelemayMJSystematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudicationBr J Surg201299162821928409
   PubMed Web of Science ®Google Scholar
• LiuJWuYLiZLiWWangSEndovascular treatment for intermittent claudication in patients with peripheral arterial disease: a systematic reviewAnn Vasc Surg20142897798224342830
   PubMed Web of Science ®Google Scholar
• MazariFAKhanJACarradiceDRandomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial diseaseBr J Surg201299394822021102
   PubMed Web of Science ®Google Scholar
• RegensteinerJGExercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatmentCurr Drug Targets Cardiovasc Haematol Disord2004423323915379615
   PubMedGoogle Scholar
• McDermottMMLiuKGuralnikJMHome-based walking exercise intervention in peripheral artery disease: a randomized clinical trialJAMA2013310576523821089
   PubMed Web of Science ®Google Scholar
• MaysRJRogersRKHiattWRRegensteinerJGCommunity walking programs for treatment of peripheral artery diseaseJ Vasc Surg2013581678168724103409
   PubMed Web of Science ®Google Scholar
• StevensJWSimpsonEHarnanSSystematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudicationBr J Surg2012991630163823034699
   PubMed Web of Science ®Google Scholar
• PandeRLHiattWRZhangPHittelNCreagerMAMcDermottMA pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudicationVasc Med20101518118820385711
   PubMed Web of Science ®Google Scholar
• AhimastosAAWalkerPJAskewCEffect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication, a randomized controlled trialJAMA201330945346023385271
   PubMed Web of Science ®Google Scholar
• ShahinYMazariFChetterIDo angiotensin-converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trialsInt J Surg2011920921321195215
   PubMed Web of Science ®Google Scholar
• SobieszczykPEisenhauerAManagement of patients after endovascular interventions for peripheral artery diseaseCirculation201312874975723940389
   PubMed Web of Science ®Google Scholar
• DakeMDAnselGMJaffMRPaclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study resultsCirc Cardiovasc Interv2011449550421953370
   PubMed Web of Science ®Google Scholar
• StroblFFBrechtelKSchmehlJTwelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery diseaseJ Endovasc Ther20132069970624093324
   PubMed Web of Science ®Google Scholar
• IidaOYokoiHSogaYCilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol studyCirculation20131272307231523652861
   PubMed Web of Science ®Google Scholar
• KrankenbergHSchlüterMSteinkampHJNitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)Circulation2007116328529217592075
   PubMed Web of Science ®Google Scholar
• DickPWallnerHSabetiSBalloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesionsCatheter Cardiovasc Interv20097471090109519859954
   PubMed Web of Science ®Google Scholar